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for chest pain significantly later than Euro-American women. Once hospital-
ized, diagnostic evaluation between the two groups is similar.
comparable to standard balloon angioplasty. Its effect on reducing late lumen
loss (angiographic restenosis) compared with balloon angioplasty is under-
going evaluation in a randomized, Phase II clinical trial.
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Vibrational angioplasty is a novel method of angioplastywhich is particularly
suitable for the treatment of chronic total occlusions. Vibrational angioplasty
utilises a hand held motor which is attached to a conventional catheter and
guide wire. This device consists of a motor and gearing system producing a
fine rapid reciprocation and random motion in a flexible guide wire. In vitro
studies have shown that this system generates reciprocal motion in a guide
wire with random oscillations of 2 times the reciprocating frequency. The
range of movement of the wire is dependant on the frequency of vibration
and degree of flexibility of the wire together with the lateral motion of the
vibrating 'shuttle' ih the device. We present the first 18 cases (12 male 6 fe-
male, mean age 59.8 yrs range 40-73) of chronic total occlusion treated with
the new version of this device. All patients had symptoms of stable angina.
Arteries treated were left anterior descending:8,left circumflex:4, right coro-
nary artery:6. In all 18 cases there was a failure to cross the lesion with con-
ventional techniques and wires. The mean duration of the occlusions was
17.03 months (range:4-60 months). In 16/18 cases successful crossing was
achieved with vibration In 2118 cases where a wire managed to cross the le-
sion no balloon could subsequently cross the lesion. In 14/18 cases lesions
were crossed successfully by a balloon and PTCA was performed with pres-
sure ranging between 2.5-6 Atm. The post procedural result was: uncom-
plicated in 9/18, complicated by moderate dissection treated conservatively
in 1/18 cases, by major dissection needed stenting in 2/18, compromised
by the evidence of severe diffuse disease distally in 2/18 and regarded as
unsuccessful in 4/18. The total procedural and screening times (mean ± SD)
were 73.2 ± 31 .3 and 41 .2 ± 16.4 min respectively. In conclusion "vibrational
angioplasty" appears to achieve high primary success rates in the recanal-
isation of totally occluded arteries. Further studies are needed to clarify its
mechanism of action, the vessel wall changes due to vibrational' energy and
their impact on restenosis.
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We report the results of initial in-vitro and in-vivo testing of a new, ultrasound-
guided directional coronary atherectomy (GDCA) catheter (DVI, Redwood
City, CA) which is being developed as a potential first-generation clinical prod-
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Therapeutic ultrasonic (195 kHz) catheters with 1.2 or 1.7 mm ball tips for
coronary angioplasty have recently been developed. During the first phase
of a multi-center European trial (CRUSADE) this system was evaluated in 100
patients (86% male, mean age 57 years) with symptomatic coronary artery
disease or acute myocardial infarction. Lesions were located in the LAD (n =
61), CX (n = 17), and RCA (n = 22); 62% were type B or C; 11 lesions were
restenotic, 19 occlusive, 9 longer than 20 mm, 37 calcified, 18 thrombotic,
and 15 collateralised.
Results: The ultrasound catheter crossed 82/100 lesions, adjunctive bal-
loon angioplastywas needed in 98 lesions. There was no death and myocar-
dial infarction, or CABG in the first 24 hours. There was no perforation, but
2 acute vessel closures; intimal cleft or dissection was seen in 17 lesions of
which 1 required stenting. Procedural success was obtained in 93%. At 24
hours 11/100 vessels were reoccluded. At 6 months angiographic follow-up
in 51 patients restenosis (>50% stenosis) occured in 33%.
Conclusions: Therapeutic ultrasound angioplasty is a feasible and safe
new treatment modality. Adjunctive balloon angioplasty is regularly nec-
essary. Preliminary experience suggests usefulness in lesions with visible
thrombus, and undilatable or uncrossable lesions.
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To assess the angiographic outcome after "cutting" balloon (C-Ball) an-
gioplasty, a technique which uses 3-4 longitudinal microtomes to incise
atheroma reducing vascular barotrauma, we reviewed the cineangiograms of
86 patients (89 lesions) undergoing this procedure in Phase I and II clinical
studies. On-line quantitative angiography (OCA) was used by investigators
to approximate a 1:1 balloon artery ratios (BAR). In the Phase II Pilot study,
adjunct balloon PTCA was not performed unless a >40% residual diameter
stenosis remained after C-Ball. Off-line qualitative morphologic and quanti-
tative angiographic (ImageComm) analyses were performed by independent
Core Laboratory review.
Directional coronary atherectomy has been shown to be a successful
method of percutaneous coronary revascularisation, particularly in large ves-
sels with eccentric stenoses. The application of laser technology to coronary
revascularisation has not been as successful, mainly because of a relatively
high rate of vessel wall perforation. We describe a combination endovascu-
lar imagingllaser atherectomy catheter (Precision Guided Directional Laser
Atherectomy Catheter, PGDLAC) that may overcome these shortcomings by
allowing precision guided intervention.
The catheter consists of a laser cutting device with an integrated imaging
system (fiberoptic or ultrasound). Fiberoptic imaging allows exact position-
ing and orientation of the laser tipped catheter within the vessel lumen, and
visual control of plaque excision. In the second step, the vessel wall mor-
phology is demonstrated using ultrasound, and the result of the intervention
assessed without removing the catheter. Excised plaque fragments are ex-
tracted by way of the catheter, Preliminary results of in vitro experimental ap-
plication of this device in human coronary arteries is promising and confirms
the technical feasibility. Such a device potentially offers the advantages of
effective, precision guided atherectomy in plaques of variable constitution,
with a potential reduction in procedure time and radiation dose.
By combining state of the art imaging and interventional technology, we
have developed a precision guided directional laser atherectomy system that
may provide more effective percutaneous coronary revascularisation than
previously developed techniques.
Tuesday, March 21,1995,4:00 p.m.-5:30 p.m.
Ernest N. Morial Convention Center, La Louisiane A
New Devices for Coronary Intervention
4:00
The Precision Guided Directional Laser Atherectomy
Catheter: A New Approach to Percutaneous
Coronary Revascularisation
Raimund Erbel, Thomas Roth, Lothar Koch, Junbo Ge, Michael Haude. Department
of Cardiology, University Essen, Germany
1760-21 Angiographic Outcome After "Cutting" Balloon
Angioplasty
Vessel 1%): RCA/LADILCx
Location (%): OstiallProximaliMid-Distal
Eccentricity (%)/Bend ~ 45" (%)
Length?: 10 mm (%)lCalcified (%)
Irregular (%)/Bifurcation (%)
ACC/AHA Class (%): A/B1/82/C
Reference Diameter, mm/C-Ball :Artery Ratio
MLD, mm: PrelPost C-BalllFinal
% Stenosis: PrelPost C-BalilFinal
% Adjunct PTCA/% Post-PTCA haziness
Final NHLBI Dissection (%): Grade BICID
Two patients in Phase II required intracoronary stents for dissections af-
ter C-Ball and adjunct PTCA. There were no deaths and no patient required
emergency CABG. We conclude that "cutting" balloon PTCA: (1) can be per-
formed safely without an untoward increase in dissections or other angio-
graphic complications; and (2) results in a residual diameter stenosis (29%)
